Proton Pump Inhibitors (PPIs): Medications like omeprazole (Prilosec) reduce stomach acid
Triple Agonists (GLP-1/GIP/Glucagon) Drug-Drug Interaction Table At a glance Prototype drug / retatrutide (LY3437943) Mechanism / simultaneous GLP-1R, GIPR, and glucagon receptor agonism Phase 2 weight loss (48 wk) / 24.2% mean body weight reduction vs 2.1% placebo Primary metabolic targets / obesity, MASLD/MASH, T2D, dyslipidemia Gastric emptying effect / marked slowing, peak drug interaction risk 1 to 4 h post-dose Oral drug most affected / warfarin, oral contraceptives, levothyroxine, cyclosporine Hypoglycemia risk / low monotherapy
The requirements of statistical analyses determined the total number of animals used, the Three Rs (3Rs), and the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments)
The type and intensity of side effects can vary by medication, dose, health history, and individual response